SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI)
In diabetic patients with severe AS, LVEF < 50%, and EVCD undergoing TAVI, the use of SGLT2i was associated with a more favorable cardiac remodeling and a reduced risk of MACE at 2-year follow-up.
Authors
- Daniele Andreini (ORCID: https://orcid.org/0000-0002-5996-9209)
- Paolo Calabrò (ORCID: https://orcid.org/0000-0002-5018-830X)
- Michelangela Barbieri (ORCID: https://orcid.org/0000-0002-9223-5792)
- Jacopo Oreglia (ORCID: https://orcid.org/0000-0002-8406-7696)
- Emanuele Gallinoro (ORCID: https://orcid.org/0000-0002-5519-2818)
- Mateusz Orzałkiewicz (ORCID: https://orcid.org/0000-0001-8402-2650)
- Antonio L. Bartorelli (ORCID: https://orcid.org/0000-0001-9309-2917)
- Giovanni Benfari (ORCID: https://orcid.org/0000-0002-5660-6162)
- Elayne Kelen de Oliveira (ORCID: https://orcid.org/0000-0003-1430-2985)
- Tullio Palmerini (ORCID: https://orcid.org/0000-0001-9886-4031)
- Matteo Casenghi (ORCID: https://orcid.org/0000-0002-1998-6370)
- Margherita Fabroni
- Andrea Munafò (ORCID: https://orcid.org/0000-0002-5108-0579)
- Felice Gragnano (ORCID: https://orcid.org/0000-0002-6943-278X)
- Carmine Pizzi (ORCID: https://orcid.org/0000-0002-4048-675X)
- Flavio Luciano Ribichini (ORCID: https://orcid.org/0000-0002-6662-0304)
- Giuseppe Esposito (ORCID: https://orcid.org/0000-0001-8080-8218)
- Raffaele Marfella (ORCID: https://orcid.org/0000-0003-3960-9270)
- Leonardo Portolan (ORCID: https://orcid.org/0000-0001-5058-8218)
- Claudio Montalto (ORCID: https://orcid.org/0000-0002-8721-0515)
- Alfonso Ielasi (ORCID: https://orcid.org/0000-0002-5982-1669)
- Edoardo Conte (ORCID: https://orcid.org/0000-0003-1443-5788)
- Roberto Scarsini (ORCID: https://orcid.org/0000-0002-5916-8882)
- Emanuele Barbato (ORCID: https://orcid.org/0000-0002-0050-5178)
- Marta Belmonte (ORCID: https://orcid.org/0000-0002-9777-8104)
- Elisabetta Moscarella (ORCID: https://orcid.org/0000-0002-7494-4640)
- Martin Pěnička
- Matteo Armillotta (ORCID: https://orcid.org/0000-0002-7971-8052)
- Francesco Angeli (ORCID: https://orcid.org/0000-0002-8732-4512)
- Dario Pellegrini (ORCID: https://orcid.org/0000-0002-5545-585X)
- Francesco Saia (ORCID: https://orcid.org/0000-0001-9969-2649)
- Lucia Scisciola (ORCID: https://orcid.org/0000-0003-3636-4298)
- Luca Bergamaschi (ORCID: https://orcid.org/0000-0001-8273-9674)
- Nurcan Baydaroglu
- Daniele Oreste D’Atri
- Marc Vanderheyden
- Pasquale Paolisso
- Monika Shumkova (ORCID: https://orcid.org/0009-0004-1655-9367)
Institutions
- University of Milan (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
- Azienda Ospedaliera Universitaria Integrata Verona (IT)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Onze Lieve Vrouwziekenhuis Hospital (BE)
- Istituto Clinico Sant'Ambrogio (IT)
- CTO Andrea Alesini (IT)
- Federico II University Hospital (IT)
- Ospedale Sant'Anna (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1186/s12933-024-02504-8
- Citations
- 51
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 20.50